Skip to content

Journal · Transplantation · Updated 20 November 2026

Bone Marrow Transplantation

Read Bone Marrow Transplantation articles on DeepDyve. No university library needed.

Bone Marrow Transplantation has published since 1986 and covers blood and marrow transplantation and cell therapy, from donor matching and transplant complications to CAR-T treatment and registry data. It’s an official journal of the European Society for Blood and Marrow Transplantation, published by Springer Nature. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Bone Marrow Transplantation
November 2026 issue

Bone Marrow Transplantation at a glance

Full title
Bone Marrow Transplantation
Abbreviation (NLM)
Bone Marrow Transplant
Publisher
Springer Nature
Print ISSN
0268-3369
Online ISSN (eISSN)
1476-5365
First published
1986
Subjects
Transplantation
Access model
Hybrid (27% free to read in 2026)

Ways to access Bone Marrow Transplantation

27% of the articles Bone Marrow Transplantation published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 27% of Bone Marrow Transplantation articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors make their accepted manuscript public 6 months after publication, on a personal website or in a repository such as PubMed Central.
  3. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  4. A library. Your university, hospital or public library may subscribe to Bone Marrow Transplantation. Check its journal list and whether it offers remote access.
  5. DeepDyve. Read Bone Marrow Transplantation articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Recent Bone Marrow Transplantation research worth reading

Published January to March 2026. Summaries describe what the authors report.

  1. LitStreamGraft-versus-host disease · Transplantation

    Chronic graft-versus-host disease: Current situation and unmet needs — A European position statement

    In a European position statement, Malard and colleagues review the biology, epidemiology, diagnosis and management of chronic graft-versus-host disease after allogeneic transplantation, note that responses to newer therapies remain variable, and outline a roadmap built on biomarker-driven precision medicine.

    Malard et al. · Bone Marrow Transplantation, published online March 7, 2026 · DOI 10.1038/s41409-026-02817-0

  2. Open accessPediatric transplantation · Guidelines

    Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT)

    An EBMT expert panel sets out guidelines for preventing sinusoidal obstruction syndrome in children at high risk after stem cell transplantation, concluding that defibrotide prophylaxis is justified for them and offering a weighted scoring system to guide the decision.

    Corbacioglu et al. · Bone Marrow Transplantation, published online January 13, 2026 · DOI 10.1038/s41409-025-02793-x

  3. LitStreamLeukemia · CAR T-cell therapy

    CAR T-cell therapy in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis

    In a systematic review and meta-analysis of 40 clinical trials with 1540 patients with relapsed or refractory B-ALL, Navarro and colleagues report a pooled complete remission rate of 83.4%, with higher MRD-negative remission rates for 4-1BB than CD28 constructs.

    Navarro et al. · Bone Marrow Transplantation, published online February 14, 2026 · DOI 10.1038/s41409-026-02803-6

  4. LitStreamGut microbiome · Transplantation

    Microbiome, GvHD, and immune reconstitution in allogeneic hematopoietic cell transplantation

    Weber and colleagues review how the gut microbiome influences immune reconstitution and complications after allogeneic hematopoietic cell transplantation, including the link between dysbiosis and acute GVHD, and the microbiome-targeted strategies, such as fecal microbiota transfer, now being investigated.

    Weber et al. · Bone Marrow Transplantation, published online February 4, 2026 · DOI 10.1038/s41409-026-02798-0

  5. LitStreamLymphoma · Stem cell transplantation

    Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWP

    In a retrospective EBMT registry analysis of 73 patients with adult T-cell leukemia/lymphoma who had allogeneic stem cell transplantation, López-Pereira and colleagues report 2-year overall survival of 49% and progression-free survival of 43%.

    López-Pereira et al. · Bone Marrow Transplantation, published online January 3, 2026 · DOI 10.1038/s41409-025-02783-z

See every Bone Marrow Transplantation article on DeepDyve

Questions about Bone Marrow Transplantation

How can I read Bone Marrow Transplantation articles without a subscription?

27% of Bone Marrow Transplantation articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors make their accepted manuscript public 6 months after publication, on a personal website or in a repository such as PubMed Central. Your library may also subscribe. DeepDyve lets you read Bone Marrow Transplantation articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Bone Marrow Transplantation?

Bone Marrow Transplantation’s NLM (PubMed) abbreviation is Bone Marrow Transplant.

What is the ISSN of Bone Marrow Transplantation?

The print ISSN is 0268-3369 and the online ISSN is 1476-5365.

Is Bone Marrow Transplantation open access?

Bone Marrow Transplantation is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 78 of 287 Bone Marrow Transplantation articles (27%) carry a Creative Commons license, per Crossref.

Bone Marrow Transplantation articles on DeepDyve are licensed from Springer Nature. Journal facts as of 20 November 2026.

Start reading Bone Marrow Transplantation today

One month free, then less than $2 a day. Bone Marrow Transplantation, plus millions of articles from thousands of journals.

Start free month

Like this: